| Breakdown |
|---|
Income Statement |
| Total Revenue |
| Gross Profit |
| EBITDA |
| Net Income |
Balance Sheet |
| Total Assets |
| Cash, Cash Equivalents and Short-Term Investments |
| Total Debt |
| Total Liabilities |
| Stockholders Equity |
Cash Flow |
| Free Cash Flow |
| Operating Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | ― | ― | ― | ― | ― | ― | |
77 Outperform | $140.82B | 22.21 | 11.16% | 3.40% | 2.21% | -16.95% | |
75 Outperform | $7.11B | 18.70 | 8.00% | 5.35% | 1.96% | -35.00% | |
70 Outperform | $6.25B | 8.05 | 13.35% | 12.98% | -0.38% | -53.94% | |
69 Neutral | $16.11B | 54.72 | 6.28% | 4.93% | 8.14% | ― | |
65 Neutral | $9.63B | 8.24 | 23.02% | 5.06% | -1.55% | 12.83% | |
61 Neutral | $56.74B | 26.77 | 7.10% | 2.97% | 9.07% | -28.58% |